$63.96-0.63 (-0.98%)
LyondellBasell Industries N.V.
LyondellBasell Industries N.V. in the Basic Materials sector is trading at $63.96 with a market capitalization of $20.5B. Wall Street consensus targets $68.35 (17 analysts), implying a +6.9% move over the next 12 months. The stock is currently 24% below its 52-week high of $83.94, remaining 7.5% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.18B↑ | $7.20B↑ | $7.09B↓ | $7.73B↑ | $7.66B |
| Gross Profit | $2.04B↑ | $701.00M↑ | $335.00M↓ | $906.00M↑ | $787.00M |
| Operating Income | $1.62B↑ | $254.00M↑ | -$71.00M↓ | $471.00M↑ | $317.00M |
| Net Income | $558.00M↑ | $123.00M↑ | -$142.00M↑ | -$892.00M↓ | $114.00M |
LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, China, Mexico, Italy, Japan, France, Poland, the Netherlands, and internationally. It operates in five segments: Olefins and PolyolefinsAmericas; Olefins an...

Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

LyondellBasell Industries (NYSE:LYB) drew fresh attention after a report linked it to early stage bids for Shell’s U.S. chemicals business, an asset that could be valued around US$8b. See our latest analysis for LyondellBasell Industries. The Shell chemicals bid talk comes after a busy spell for LyondellBasell Industries, with its share price now at US$65.20 and a year to date share price return of 46.88%. That sits alongside a 1 year total shareholder return of 21.49%. However, the 3 year...
US equity indexes ended higher Tuesday as crude oil prices and government bond yields dropped, after

SHEL's potential $8B U.S. chemicals exit marks a sharper focus on oil and gas as it cuts costs and reshapes capital allocation.
Academic risk and quality models computed from LYB's own filings and price history, not from analyst opinion.
Weak: only 2 of 9 fundamental-health tests pass, which is the range associated with deteriorating fundamentals.
Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 36.6% reading.
Fama-French 5-factor market beta. The five factors explain 7% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.